Following 70 years of expertise investigating some of the most widespread and harmful viruses such as HIV, influenza and Ebola, Kyoto University’s Institute for Life and Medical Sciences is developing ...
Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.
COVID-19 infection can be halted by compounds from Copaifera lucens leaves that block both viral entry into cells and the ...
More than 250 million people worldwide live with chronic hepatitis B (HBV), yet there is still no accessible animal model for studying the disease or testing novel therapies. Researchers have now ...
April 22, 2026 expert reaction to study looking at whether a bat alphacoronavirus can enter human cells . A study published in Nature looks at whether a bat alphacoronavirus can b ...
Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first ...
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) ...
DNA replication is the biological process by which an exact copy of a deoxyribonucleic acid (DNA) molecule is created and it is the basis for biological inheritance. Each of the two strands of the DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results